Comparison

Metixene hydrochloride hydrate European Partner

Item no. TMO-TQ0304-5mg
Manufacturer TargetMol
CASRN 7081-40-5
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles O.Cl.CN1CCCC(CC2c3ccccc3Sc3ccccc23)C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
AChR
Storage Conditions
-20
Molecular Weight
363.95
Description
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease.
Pathways
Neuroscience

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close